The phagocyte NADPH oxidase is a multicomponent enzyme complex mediating microbial killing. We find that NADPH oxidase p47 phox -deficient (p47 phoxÀ/À ) chronic granulomatous disease (CGD) mice develop lymph node hyperplasia even without obvious infection, where increased number of T and B lymphocytes is associated with increased percent of naïve cells and a lower T : B cell ratio than wild type. Paradoxically, despite lymphoid hyperplasia in vivo, when lymphocytes are placed in culture, p47 phoxÀ/À CD8 þ lymphocytes progress more rapidly to apoptosis than wild type. This is associated in cultured p47
The phagocyte NADPH oxidase is a multicomponent enzyme complex mediating microbial killing. We find that NADPH oxidase p47 phox -deficient (p47 phoxÀ/À ) chronic granulomatous disease (CGD) mice develop lymph node hyperplasia even without obvious infection, where increased number of T and B lymphocytes is associated with increased percent of naïve cells and a lower T : B cell ratio than wild type. Paradoxically, despite lymphoid hyperplasia in vivo, when lymphocytes are placed in culture, p47 phoxÀ/À CD8 þ lymphocytes progress more rapidly to apoptosis than wild type. This is associated in cultured p47
phoxÀ/À CD8 þ lymphocytes with the induction of proapoptotic Bim and Puma expression, increased mitochondrial outer membrane permeabilization and depressed Bcl-2 expression. Addition of IL-7 to the culture partially corrects Bcl-2 levels in cultured p47 phoxÀ/À CD8 þ lymphocytes and improves the survival. Adding glucose oxidase to the culture to generate hydrogen peroxide along with IL-7 further improves p47 phoxÀ/À CD8 þ lymphocyte survival, but only to 30% of wild type. We conclude that p47 phoxÀ/À CD8 þ lymphocytes have an intrinsic survival defect likely in part related to the oxidase deficiency, but in vivo in lymph nodes of CGD mice, there are microenvironmental factors yet to be delineated that suppress the progression of apoptosis and allow the accumulation of lymphocytes leading to lymphoid hyperplasia. Within the complex microarchitecture of secondary lymphoid organs (SLOs), such as lymph nodes (LNs) and spleen, critical signals balance lymphocyte survival and homeostasis. Self-major histocompatibility molecule stimulation of the T-cell receptor (TcR) and extrinsic signals provided by cytokines, such as IL-7 and IL-15 control naïve T-lymphocyte survival. 1, 2 In addition, these signals facilitate continuous low-level division of resting naïve T cells during homeostatic proliferation to maintain T-cell number and repertoire diversity. 2 Homeostasis is disrupted during the mounting of an immune response allowing for clonal expansion of effector lymphocytes. Thereafter, the majority of effector cells die to prevent undesirable autoimmunity, and a subset survives as memory T cells. 3, 4 Immune responses are mounted within SLOs to eradicate invading pathogens. However, impaired pathogen clearance in an immunocompromised host often results in sustained immune responses that produce local acute inflammatory responses and ultimately systemic chronic inflammation.
Resting naïve T cells recirculate between blood and lymphoid tissues, whereas memory T cells migrate to nonlymphoid tissue sites. Furthermore, without antigen encounter, resting naïve T cells eventually die within a defined half-life. 5, 6 Survival of resting naïve T cells during recirculation between inflamed and noninflamed SLOs undoubtedly requires different signals than those required for survival during recirculation between noninflamed SLOs. In this manuscript, we examined the relationship between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase deficiency and naïve T-cell survival within SLOs. The phagocyte multicomponent, NADPH oxidase, mediates the single electron reduction of oxygen to superoxide anion resulting in the well-characterized respiratory burst, which promotes innate cell killing of catalase-positive microorganisms. 7, 8 Several nonphagocytic cells have been reported to express ligand-dependent NADPH oxidase-like reactive oxygen species (ROS). 9 We reported that T cells express each of the NADPH oxidase structural proteins and TcR stimulation induces low level intracellular NADPH oxidase-dependent hydrogen peroxide. 10 Chronic granulomatous disease of childhood (CGD) is the genetically inherited primary immunodeficiency, that is caused by defects of structural NADPH oxidase proteins. 11 CGD patients are at increased risk of developing and succumbing to life-threatening infection and acute and chronic inflammatory diseases. 12 Here, we report that NADPH oxidase p47 phox -deficient (p47 phoxÀ/À ) mice without the evidence of gross infection develop reactive SLOs characterized by LN hyperplasia with increased B-and T-lymphocyte accumulations. 13 Figure 1) . In vivo 5-bromo-2 0 deoxyuridine (BrdU) incorporation studies demonstrated that the peripheral LN CD4 þ lymphocyte turnover was similar in p47 phoxÀ/À and WT mice, whereas p47 phoxÀ/À CD8 þ CD44 high T cells proliferated 1.5 times more than WT cells (Figure 1c ). Peripheral LN p47 phoxÀ/À B cells also hyperproliferated compared to WT B cells (Figure 1d) . Collectively, these data show that within the reactive p47 phoxÀ/À LN microenvironment, there is increased B-cell and memory CD8 þ -cell divisions along with an increased accumulation of naïve B and T lymphocytes.
Exaggerated death of p47
phoxÀ/À CD8 þ lymphocytes. Numerous investigations have reported that ROS mediates apoptosis in a variety of cells including T cells. Although investigations of activated T-cell death concluded that excess ROS disrupts mitochondrial membrane integrity by perturbing the balance of Bcl-2 antiapoptotic and proapoptotic proteins, and antioxidants protect activated T cells from ROS-mediated apoptosis, 1, 6, [14] [15] [16] the role of ROS in naïve T-cell survival is less clear. To determine whether NADPH oxidase ROS mediates resting T-cell survival, we examined cytokine responses of LN-derived T lymphocytes. Viable and nonviable lymphocytes from 24 h cultures were differentially stained with DNA-binding dyes and the absolute number of viable versus nonviable nucleated cells were quantitated on the basis of cell size and staining properties using the Guava ViaCount assay (see Materials and Methods). Cell count and viability were determined and the data were normalized to the baseline values. After 24 h of culture in IL-2, fewer resting p47 phoxÀ/À CD4 þ and CD8 þ lymphocytes remained viable than WT lymphocytes. Furthermore, there was significantly more cell death of resting p47 phoxÀ/À CD8 þ lymphocytes (Figure 2 23, 24 The combination of GO (1 pg/ml) and IL-7 enhanced p47 phoxÀ/À -lymphocyte survival 10% over that seen with IL-7 alone (Figure 2d, Supplementary Figure 2 as WT cells were in late apoptosis. Consistent with the viability data in Figure 2 , p47 phoxÀ/À viable : late apoptotic cell ratios at 4 versus 24 h revealed more p47 phoxÀ/À cells continue to die in IL-2 than in IL-7 (1.4 ± 0.07 versus 0.44 ± 0.16 P ¼ 0.02 for IL-2, and 1.5 ± 0.13 versus 1 ± 0.21 for IL-7).
We also activated p47 phoxÀ/À and WT CD8 þ lymphocytes in the presence of the soluble pan-caspase inhibitor Z-VAD-FMK, and found there was no difference in the survival of p47 phoxÀ/À CD8 þ lymphocytes after 24 h (Figure 3c ). Collectively, this data indicates that p47 phoxÀ/À CD8 þ lymphocytes undergo a rapid and profound apoptosis, and the exaggerated in vitro p47 phoxÀ/À CD8 þ -lymphocyte cell death is triggered the upstream of caspase-mediated phenomenon.
Impaired survival of p47
phoxÀ/À CD8 þ cells is due to an intrinsic apoptotic pathway defect. When purified resting naïve mouse T cells are placed into in vitro culture in the absence of required survival signals, intrinsic apoptotic pathways are initiated and T cells die rapidly due to the loss of control of mitochondrial homeostasis. 27, 28 We cultured resting CD8 þ lymphocytes from WT and p47
phoxÀ/À mice as described and examined antiapoptotic Bcl-2 and proapoptotic Bax protein expression along with mitochondrial transmembrane potential (DCm) and apoptosis to determine whether the exaggerated p47 phoxÀ/À CD8 þ -lymphocyte apoptosis was due to aberrant intrinsic apoptotic pathway function. For these investigations, we performed a multiparametric vitality and apoptosis study using the cyanine dye 1,1 0 ,3,3,3 0 ,3 0 -hexamethylindodicarbo-cyanine iodide (DiIc 1 (5)) to assess DCm in combination with Annexin-V and 7-AAD to asses apoptosis. In addition, we used surface staining for CD44 to distinguish survival parameters of naïve (CD44 low ) versus activated (CD44 high ) CD8 þ cells. Consistent with the apoptosis data in Figure 2 , FSC/SSC properties of p47 phoxÀ/À cells after 3 -4 h of culture showed appreciably fewer p47 phoxÀ/À CD8 cells were viable ( Figure 4) Figure 4) , however, Bcl-2 expression was rapidly and dramatically reduced in CD44 low and CD44 high p47 phoxÀ/À CD8 þ lymphocytes compared to WT lymphocytes cultured in IL-2 for 3 h (Figure 4a) (Figure 4d , Table 1 ). 27 We also found that compared to IL-7 cultured cells, significantly more CD44 low p47 phoxÀ/À lymphocytes cultured with IL-2 showed reduced DCm (Table 1 ). In additional experiments we confirmed that in addition to the loss of DCm, dying p47 phoxÀ/À CD8 þ lymphocytes also release mitochondrial cytochrome C (Figure 4e ). For these analyses, we used a quantitative flow cytometric assay to differentiate cells with intact mitochondria (high fluorescence) from cells that had released mitochondrial cytochrome C (low fluorescence). 29, 30 As indicated in the histograms in Figure 4e , the majority of WT lymphocytes had intact mitochondria at baseline and after culture in IL-2. However, although the majority of p47 phoxÀ/À lymphocytes also had intact mitochondria at baseline after 3 h in culture, cytochrome C was released in the apoptotic p47 phoxÀ/À cells (21% ± 3 p47 phoxÀ/À versus 5 ± 0.1 WT, P ¼ 0.005). Collectively, these observations implicate a role for NADPH oxidase p47 phox as an upstream effector of the mitochondrial apoptosis pathway via regulation of the antiapoptotic protein Bcl-2.
Survival of p47 phoxÀ/À CD8 þ cells is dependent upon the lymphoid microenvironment. T-lymphocyte homeostasis is tightly controlled by multiple regulatory checkpoints that restrain T-lymphocyte differentiation within the thymus and expansion in the periphery. Post-thymic export resting naïve T cells are found concentrated in SLOs. However, resting naïve T cells are not stationary but constantly traffic between SLOs in search of antigen, thus providing an effective surveillance system within lymphoid organs. We compared survival of thymic, spleen and LN-derived resting naïve p47 phoxÀ/À CD8 þ lymphocytes to discern whether the observed survival defect could be linked to the NADPH oxidase p47 phoxÀ/À physiologic microenvironment ( Figure 5 ). We found that single positive p47 phoxÀ/À CD8 þ thymocytes survived as well as WT thymocytes, whereas significantly more splenic resting p47 phoxÀ/À CD8 þ lymphocytes rapidly succumb during the initial 3-4 h of in vitro culture in IL-2 or IL-7 similar to LN (Figure 2) 
CD8
þ lymphocytes expressed significantly more Bim EL and Bim L as well as Puma (Figure 6 ). For spleen, WT and p47 phoxÀ/À CD8 þ lymphocytes showed comparable Bim and Puma expressions at baseline (data not shown). However, similar to LN, Bim EL and Puma were significantly induced 10 These observations suggested a role of NADPH oxidase-mediated ROS in T-cell function. We report that post-thymic resting naïve p47 phoxÀ/À CD8 þ cells exhibit an intrinsic survival defect. We link the defect to higher levels of intrinsic apoptotic pathway activity in p47 phoxÀ/À CD8 þ lymphocytes in vitro and showed that naïve CD44 low p47 phoxÀ/À lymphocytes have lower Bcl-2 levels that are only partially rescued by prosurvival cytokine IL-7. We also found that in vitro p47 phoxÀ/À CD8 þ -lymphocyte survival could be distinguished by BH3-only Bim and Puma protein expression. Although Bim and Puma were significantly reduced in isolated LN p47 phoxÀ/À CD8 þ lymphocytes, protein expression in splenic p47 phoxÀ/À CD8 þ lymphocytes was comparable to WT lymphocytes. Interestingly, both proteins were induced in vitro in LN and splenic p47 phoxÀ/À CD8 þ lymphocytes indicating that enhanced Bim and Puma expression regulates the rapid in vitro death of p47 phoxÀ/À cells. Supplementing cultures with exogenous IL-7 in vitro normally regulates cellular Bcl-2 proteins to maintain equilibrium of antiapoptotic and proapoptotic proteins. However, even with the addition of IL-7 leading to a demonstrative reduction in resting p47 phoxÀ/À lymphocyte death after 24 h in culture, the overall survival of p47 phoxÀ/À lymphocytes was only 61%, Po0.0001, of WT cells. Thus, indicating that additional and as yet defined signaling events may be aberrant in p47 phoxÀ/À lymphocytes. On the basis of our observation that NADPH oxidase-dependent H 2 O 2 is differentially regulated in activated T-cell blasts, 10 we asked whether the aberrant death of p47 phoxÀ/À CD8 þ cells was due to H 2 O 2 deficiency. To avoid the potential of causing oxidative stress in our in vitro culture model, 32 phoxÀ/À CD8 þ -cell survival suggests an optimum physiologic H 2 O 2 concentration released at the appropriate time during cytokine stimulation maybe a previously unrecognized pivotal, although partial, signal for lymphocyte survival. We plan to examine these questions in future investigations.
Immune responses are mounted within SLOs to eradicate invading pathogens. However, impaired pathogen clearance in immunocompromised host often results in sustained immune responses. Furthermore, the persistent immune challenge experienced by immunocompromised host undermines the need to maintain a consistent level of naïve T cells capable of regulating homeostasis. Our findings putatively implicate a role for dynamic physiologic cues generated within reactive SLO microenvironments that balance and modulate the transition to effector cells without exhausting naïve CD8 þ lymphocytes. We propose NADPH oxidase p47 phox and/or NADPH oxidase-mediated ROS is/are a regulator of these adaptive immune phenomenon. The mechanisms appear to involve the regulated suppression of prosurvival members of the Bcl-2 protein family that protect post-thymic naïve CD8 þ lymphocytes from Bim and Puma driven apoptosis as well as through mechanisms associated with the removal of in vivo suppressive factor(s) that allow enhanced apoptotic BH3-only protein expression in vitro. This indicates that the characterization of molecular pathways that are controlled by NADPH oxidase p47 phox and/or NADPH oxidase-mediated ROS may discern previously unrecognized targets for the development of immunomodulatory therapies.
Materials and Methods
Mice. p47 phox -deficient mice have been described. 13 Congenic p47 phoxÀ/À mice are on a C57BL/6NTac background. WT control mice (C57BL/6NTac) were obtained from Taconic Farms (Hudson, NY). Animal care was provided in accordance with Institutional Animal Care and Use Committee procedures approved by NIAID/NIH. NADPH oxidase-deficient mice were housed in aseptic conditions. Tissues showing gross evidence of infection were discarded and not used for the investigations reported. phoxÀ/À mice were generated and pooled. A total of 10 Â 10 6 LN cells were transferred into Ly5.1 congenic recipient mice (n ¼ 3). After 24 h, the recipients were killed, and lymph nodes and spleen were harvested and stained for surface markers. Cells were gated on CD45. Cell isolation. Lymph node single cell suspensions were prepared from peripheral mouse LNs or thymus. CD4 þ and CD8 þ T cells were negatively selected using the Dynal bead mouse CD4-or CD8-negative isolation kit (Invitrogen Corp., Carlsbad, CA) according to the manufacturer's protocol. The purity of each cell population was 498% as determined by flow cytometry.
Cell culture and stimulation. Lymph node purified CD4 or CD8 T lymphocytes were cultured at a concentration of 1 Â 10 6 cell/ml in IMDM complete : IMDM (Gibco/Invitrogen Corp.) containing 10% FBS (Hyclone Laboratories, Logan, UT), 2.0 mM L-glutamine (Hyclone), 50 mM b-mercaptoethanol (b-ME, Sigma Aldrich, St. Louis, MO) and 100 U/ml penicillin and 10 U/ml streptomycin (Gibco/Invitrogen Corp.) supplemented with 10 U/ml rhIL-2 (Rohmann-LaRoche Inc., Nutley, NJ) or 100 ng/ml IL-7 (PeproTech, Rocky Hill, NJ). For initial experiments, cells were cultured using 10 -100 U/ml rhIL-2. There was no difference in the relative cell viability differences between WT and p47 phoxÀ/À cells using 100 U/ml of IL-2. Subsequently for later experiments, the cells were cultured using 10 U/ml IL-2.
Caspase inhibition. Lymph node purified CD8 þ T cells were cultured in IMDM complete and supplemented with 10 U/ml rhIL-2 or 100 ng/ml IL-7, and treated with 50 mM Z-VAD (OMe)-FMK (EMD Chemicals, San Diego, CA).
Cell counts and viability. Resting CD4 þ or CD8 þ LN cells were incubated with IL-2 or IL-7 as indicated, and cell count and viability were determined. Viable and nonviable lymphocytes from cultures were differentially stained with DNAbinding dyes and the absolute number of viable versus nonviable nucleated cells were quantitated on the basis of cell size and staining properties using the Guava ViaCount (Guava Technologies, Hayward, CA) assay. Cells were diluted with the Guava Viacount (Guava Technologies) reagent in a total volume of 400 ml at the indicated time intervals. Cell counts and viable and dead cell numbers were determined using Guava ViaCount Software on the Guava PCA (Guava Technologies).
Antibodies, immunofluorescent staining and flow cytometry. Fluorescein isothiocyanate (FITC)-conjugated monoclonal antibodies (mAB) against CD11b (Mac-1), Gr-1, B220, CD44, CD25 and (BD Pharmingen,); R-phycoerythrin (PE)-conjugated mAB against B220, CD27, CD62L, CD69 and CD127 (IL-7R; BD Pharmingen); allophycocyanin (APC)-conjugated CD11b, CD3, CD4 and CD8 were used. Cells were stained with the designated FITC (1 : 250), APC (1 : 250) or PE (1 : 500)-conjugated mAb or isotype control for 25 min at room temperature in 1 -2% FBS -HBSS containing purified rat antimouse CD16/CD32 Fc Block (BD Pharmingen) to minimize nonspecific binding. For the analysis, all cells were resuspended in 1 -2% FBS -HBSS containing propidium iodide (50 ng/ml; Invitrogen) to distinguish viable cells. Cell acquisition was performed on the Becton Dickinson FACSort or FACSCalibur (BD Biosciences, San Jose, CA) using CellQuest Pro software (BD Biosciences). Analysis was performed using FlowJo software (FlowJo, LCC, Ashland, OR). BrdU stimulation. p47 phoxÀ/À and WT mice were fed with BrdU (BD Pharmingen) in their drinking water at a concentration of 1 mg/ml for 5 days. LNs were harvested on day 5. Whole LN cell populations were stained with anti-CD4, CD8, CD44, B220 and BrdU antibodies (BD Pharmingen). Cell acquisition was performed on the Becton Dickinson LSRII (BD Biosciences) using CellQuest Pro software (BD Biosciences). Analysis was performed using FlowJo software (FlowJo, LCC, Ashland, OR).
Bcl-2 and Bax staining. Cells were washed twice in 1% FBS/PBS and surface stained for CD8 (1 : 500) and CD44 (1 : 125 -500) as indicated. Cells were fixed according to the (Cytofix/Cytoperm Plus Kit, BD Pharmingen) manufacturer's protocol. Cells were stained for intracellular Bcl-2 (BD Pharmingen) or Bax (Santa Cruz, Santa Cruz, CA) according to the manufacturer's protocol. Conformational change in the Bax protein was assessed by intracellular immunostaining using a specific antibody that recognizes only the proapoptotic conformation : anti-Bax (6A7; BD Pharmingen) using the method described by Gómez-Benito et al. 29 Briefly, cells were cultured with IL-2 supplemented medium for 3 h. Then, 1 Â 10 6 cells were fixed with 0.5% paraformaldehyde in PBS for15 min at 41C and incubated for 25 min at room temperature with 0.5 mg of anti-Bax or a mouse IgG isotype control (BD Pharmingen) in 100 ml of PBS containing 0.1% saponin and 5% goat serum. Cells were washed with 0.03% saponin in PBS and incubated with a FITC-labeled antimouse IgG antibody (BD Pharmingen) at room temperature. Cell acquisition was performed on the Becton Dickinson FACSCalibur (BD Biosciences) using CellQuest Pro software (BD Biosciences). Analysis was performed using FlowJo software (FlowJo, LCC, Ashland, OR).
Cytochrome C release. Quantitative analysis of cytochrome C release from mitochondria was assessed by a modification of the method described by Waterhouse and Trapani. 29, 30 Briefly, cells were cultured with IL-2 supplemented medium for 3 h. Then, 1 Â 10 6 cells were permeabilized with 100 ml of digitonin (50 mg/ml in PBS containing 100 mM KCl) for 5 min on ice, fixed in 4% paraformaldehyde in PBS for 20 min at room temperature, and resuspended in 3% bovine serum albumin, 0.05% saponin in PBS (blocking buffer). Cells were incubated overnight at 41C with a 1 : 500 dilution of anti-cytochrome C antibody (InnoCytet Flow Cytometric Cytochrome C Release Kit, Calbiochem, EMD Chemicals, Inc., Gibbstown, NJ) in blocking buffer, washed, and then incubated with a 1 : 300 dilution of FITC-labeled anti-mouse IgG antibody (InnoCytet Flow Cytometric Cytochrome C Release Kit, Calbiochem). Control cells were stained with a 1 : 300 dilution of the FITC-labeled anti-mouse IgG antibody in the absence of a primary antibody. Cell acquisition was performed on the Becton Dickinson FACSCalibur (BD Biosciences) using CellQuest Pro software (BD Biosciences). Analysis was performed using FlowJo software (FlowJo).
Cell death analysis. Lymph node purified CD8
þ T cells were cultured as indicated. Cells were harvested at the designated time, washed with 1%FBS/PBS and stained for surface CD8 and CD44 (BD Pharmingen). Mitochondrial membrane integrity and cell death were determined using the Mitoprobe kit (Invitrogen) or the Annexin V: PE Apoptosis Detection Kit I (BD Pharmalgen) according to the manufactures protocols.
Glucose oxidase stimulation. Lymph node purified CD8
þ T cells were cultured in IMDM complete without b-ME and supplemented with 10 U/ml rhIL-2 or 100 ng/ml IL-7. Cells were treated with the following range of GO (Sigma-Aldrich): log 10 concentration, 10 ng/ml -1 pg/ml and log2 concentrations, 0.3 -1.2 pg/ml. Cells counts were determined at 24 h using Guava ViaCount Software on the Guava PCA (Guava Technologies).
Cell fractionation and Western blot analysis. After CD8 isolation, cells were counted and resuspended at 1 Â 10 6 cells/ml in IMDM complete with 10 U/ml rhIL-2 (Rohmann-LaRoche Inc.) for 1.5 h, and then washed with cold PBS. Cells were lysed in ice-cold mammalian protein extraction reagent (Pierce Biotechnology, Rockford IL), 1X mammalian protease inhibitor (Sigma-Aldrich) and 5 mM EDTA followed by sonication for 10 min. Insoluble material was removed by centrifugation at 12 000 Â g at 41C for 10 min. Equivalent amounts of protein were denatured in Laemmli buffer for direct resolution by 10-20% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to a nitrocellulose membrane (Millipore Corporation, Billerica, MA). Immunoblotting was performed using antiPuma Ab, anti-Bim Ab, anti-BMF Ab, (Cell Signaling Technology, Danvers, MA), anti-Mcl-1 Ab, (Abcam Inc., Cambridge, MA) anti-actin Ab (Sigma-Aldrich), HRPconjugated antirabbit Ab and HRP-conjugated antimouse Ab (GE Healthcare, Piscataway, NJ). Immunoreactive proteins were visualized using an ECL detection kit (GE Healthcare) upon exposure to BioMaxt light film (Kodak). For the relative quantification of the proteins, scanned images were analyzed using Image J. 33 Statistical analysis. Means and S.E.M. of cell count and viability were determined. Differences between the group means were analyzed by the Student's t-test. (Prism 4, GraphPad Software Inc. San Diego, CA).
